Pharmaceutical company Wockhardt on Monday announced that it has partnered with the Russian Direct Investment Fund to produce and supply Sputnik V and the one-shot Sputnik Light vaccines against COVID-19. The agreement has been laid out by the Sputnik maker's coordination partner ENSO Healthcare.